Quoin Pharmaceuticals (QNRX) Competitors $7.72 +0.30 (+3.98%) Closing price 03:58 PM EasternExtended Trading$7.72 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QNRX vs. COCH, NXL, HSDT, IINN, ICU, ALUR, CTCX, BTCY, CODX, and CHEKShould you be buying Quoin Pharmaceuticals stock or one of its competitors? The main competitors of Quoin Pharmaceuticals include Envoy Medical (COCH), Nexalin Technology (NXL), Helius Medical Technologies (HSDT), Inspira Technologies OXY B.H.N. (IINN), SeaStar Medical (ICU), Allurion Technologies (ALUR), Carmell (CTCX), Biotricity (BTCY), Co-Diagnostics (CODX), and Check-Cap (CHEK). These companies are all part of the "medical equipment" industry. Quoin Pharmaceuticals vs. Its Competitors Envoy Medical Nexalin Technology Helius Medical Technologies Inspira Technologies OXY B.H.N. SeaStar Medical Allurion Technologies Carmell Biotricity Co-Diagnostics Check-Cap Envoy Medical (NASDAQ:COCH) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk. Do institutionals and insiders believe in COCH or QNRX? 8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 58.9% of Envoy Medical shares are held by company insiders. Comparatively, 13.5% of Quoin Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, COCH or QNRX? Envoy Medical has a beta of 2.09, indicating that its stock price is 109% more volatile than the S&P 500. Comparatively, Quoin Pharmaceuticals has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Which has better valuation and earnings, COCH or QNRX? Quoin Pharmaceuticals has lower revenue, but higher earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvoy Medical$222K155.37-$20.80M-$1.43-1.12Quoin PharmaceuticalsN/AN/A-$8.96M-$41.45-0.19 Is COCH or QNRX more profitable? Quoin Pharmaceuticals has a net margin of 0.00% compared to Envoy Medical's net margin of -10,961.26%. Envoy Medical's return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Envoy Medical-10,961.26% N/A -236.14% Quoin Pharmaceuticals N/A -210.50%-99.41% Does the media favor COCH or QNRX? In the previous week, Envoy Medical had 3 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 3 mentions for Envoy Medical and 0 mentions for Quoin Pharmaceuticals. Envoy Medical's average media sentiment score of 0.33 beat Quoin Pharmaceuticals' score of 0.00 indicating that Envoy Medical is being referred to more favorably in the media. Company Overall Sentiment Envoy Medical Neutral Quoin Pharmaceuticals Neutral Do analysts recommend COCH or QNRX? Envoy Medical presently has a consensus target price of $9.25, indicating a potential upside of 477.15%. Given Envoy Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Envoy Medical is more favorable than Quoin Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryEnvoy Medical beats Quoin Pharmaceuticals on 10 of the 15 factors compared between the two stocks. Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QNRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNRX vs. The Competition Export to ExcelMetricQuoin PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.55M$2.69B$6.11B$10.53BDividend YieldN/A53.56%5.51%4.67%P/E Ratio-0.1923.8285.6926.92Price / SalesN/A610.31583.01184.15Price / CashN/A28.3526.3031.10Price / Book0.225.5813.246.71Net Income-$8.96M$32.78M$3.30B$276.35M7 Day Performance7.30%4.90%4.64%3.10%1 Month Performance2.59%10.52%8.36%10.19%1 Year Performance-54.78%-1.51%87.97%40.37% Quoin Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNRXQuoin Pharmaceuticals0.704 of 5 stars$7.72+4.0%N/A-56.4%$4.55MN/A-0.194Positive NewsCOCHEnvoy Medical2.8366 of 5 stars$0.78-3.0%$9.25+1,092.5%-75.6%$16.69M$220K-0.5434News CoverageShort Interest ↓Gap UpTrading HaltedNXLNexalin Technology2.4764 of 5 stars$0.92-3.5%$5.00+445.1%+41.0%$16.19M$174.81K-1.213Positive NewsHSDTHelius Medical Technologies1.6781 of 5 stars$14.89+3.3%N/A-95.6%$16.08M$520K-0.0130Gap UpHigh Trading VolumeIINNInspira Technologies OXY B.H.N.2.8835 of 5 stars$1.27flat$2.00+57.5%-13.1%$16.03MN/A0.0020Positive NewsShort Interest ↓ICUSeaStar Medical0.4374 of 5 stars$0.57-5.0%N/A-84.6%$15.91M$766K-0.222Gap DownALURAllurion Technologies1.9883 of 5 stars$2.05+4.6%$22.83+1,013.8%-88.4%$15.91M$32.11M-0.16501News CoverageCTCXCarmellN/A$0.74flatN/A+110.1%$15.47M$32.84K0.0014BTCYBiotricityN/A$0.53-1.9%N/A+62.0%$14.17M$12.06M-0.4940CODXCo-Diagnostics4.3604 of 5 stars$0.34-7.1%$5.50+1,498.8%-70.3%$13.25M$3.91M-0.30100Short Interest ↓CHEKCheck-Cap0.0557 of 5 stars$2.12-9.4%N/A+47.6%$12.40MN/A-0.7180 Related Companies and Tools Related Companies COCH Competitors NXL Competitors HSDT Competitors IINN Competitors ICU Competitors ALUR Competitors CTCX Competitors BTCY Competitors CODX Competitors CHEK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QNRX) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quoin Pharmaceuticals, Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Quoin Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
